• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 感染与疫苗接种的免疫学表现综述。

Review of Immunologic Manifestations of COVID-19 Infection and Vaccination.

机构信息

F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, D4005, Los Angeles, CA 90048, USA.

Carl J. and Ruth Shapiro Cardiovascular Center, Brigham and Women's Hospital, 70 Francis Street, Boston, MA 02115, USA.

出版信息

Cardiol Clin. 2022 Aug;40(3):301-308. doi: 10.1016/j.ccl.2022.03.006. Epub 2022 Mar 29.

DOI:10.1016/j.ccl.2022.03.006
PMID:35851453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8960179/
Abstract

We herein summarize currently available and clinically relevant information regarding the human immune responses to SARS-CoV-2 infection and vaccination, in relation to COVID-19 outcomes with a focus on acute respiratory distress syndrome (ARDS) and myocarditis.

摘要

我们在此总结了目前有关人类对 SARS-CoV-2 感染和疫苗接种的免疫反应的相关信息，重点关注与急性呼吸窘迫综合征（ARDS）和心肌炎相关的 COVID-19 结局。

相似文献

1
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination.COVID-19 感染与疫苗接种的免疫学表现综述。
Cardiol Clin. 2022 Aug;40(3):301-308. doi: 10.1016/j.ccl.2022.03.006. Epub 2022 Mar 29.
2
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination.COVID-19 感染与疫苗接种的免疫学表现综述。
Heart Fail Clin. 2023 Apr;19(2):177-184. doi: 10.1016/j.hfc.2022.08.006.
3
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination.COVID-19 感染与疫苗接种的免疫表现综述。
Rheum Dis Clin North Am. 2025 Feb;51(1):111-121. doi: 10.1016/j.rdc.2024.09.001.
4
Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populations.免疫功能正常和免疫功能低下的癌症患者接种 SARS-CoV-2 疫苗后的体液和细胞免疫反应。
Microbiol Spectr. 2024 Mar 5;12(3):e0205023. doi: 10.1128/spectrum.02050-23. Epub 2024 Feb 14.
5
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
6
Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.1273-mRNA 新冠病毒疫苗接种后长期血液透析患者中产生强烈细胞和体液免疫应答。
Front Immunol. 2022 Mar 23;13:845882. doi: 10.3389/fimmu.2022.845882. eCollection 2022.
7
Pediatric humoral immune responses and infection risk after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and two-dose vaccination during SARS-CoV-2 omicron BA.5 and BN.1 variants predominance in South Korea.韩国严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染和两剂疫苗接种后，在 SARS-CoV-2 奥密克戎 BA.5 和 BN.1 变体为主导期间，儿童体液免疫反应和感染风险。
Front Immunol. 2023 Dec 20;14:1306604. doi: 10.3389/fimmu.2023.1306604. eCollection 2023.
8
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients.疾病修正疗法对 MS 患者 COVID-19 疫苗接种后体液和细胞免疫反应的影响。
Clin Transl Sci. 2022 Jul;15(7):1606-1612. doi: 10.1111/cts.13256. Epub 2022 Mar 4.
9
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.理解“混合免疫”：对严重急性呼吸综合征冠状病毒 2 感染（SARS-CoV-2）和 2019 年冠状病毒病（COVID-19）疫苗的体液免疫反应的比较和预测因素。
Clin Infect Dis. 2023 Feb 8;76(3):e439-e449. doi: 10.1093/cid/ciac392.
10
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.

引用本文的文献

1
A Pictorial Essay Describing the CT Imaging Features of COVID-19 Cases throughout the Pandemic with a Special Focus on Lung Manifestations and Extrapulmonary Vascular Abdominal Complications.一篇图文并茂的文章，描述了新冠疫情期间新冠肺炎病例的CT成像特征，特别关注肺部表现和肺外血管腹部并发症。
Biomedicines. 2023 Jul 26;11(8):2113. doi: 10.3390/biomedicines11082113.
2
Global Inequities in COVID-19 Vaccination: Associated Factors and Tools to Measure Inequality.新冠疫苗接种中的全球不平等：相关因素及不平等衡量工具
Vaccines (Basel). 2023 Jul 16;11(7):1245. doi: 10.3390/vaccines11071245.
3
COVID-19 in the Asia Pacific: Impact on climate change, allergic diseases and One Health.

本文引用的文献

1
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.以色列青少年接种BNT162b2疫苗后发生的心肌炎
N Engl J Med. 2022 Mar 10;386(10):998-999. doi: 10.1056/NEJMc2116999. Epub 2022 Jan 26.
2
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.基于信使核糖核酸的新冠病毒疫苗加强针可诱导针对严重急性呼吸综合征冠状病毒2奥密克戎变种的中和免疫力。
Cell. 2022 Feb 3;185(3):457-466.e4. doi: 10.1016/j.cell.2021.12.033. Epub 2022 Jan 6.
3
Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19.
亚太地区的新冠疫情：对气候变化、过敏性疾病和“同一健康”理念的影响
Asia Pac Allergy. 2023 Mar;13(1):44-49. doi: 10.5415/apallergy.0000000000000021. Epub 2023 Apr 28.
BNT162b2 mRNA 疫苗接种后细胞和体液功能反应在 COVID-19 初治和恢复期患者中具有纵向差异。
Cell Rep. 2022 Jan 11;38(2):110235. doi: 10.1016/j.celrep.2021.110235. Epub 2021 Dec 21.
4
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination.自然感染或 BNT162b2 疫苗接种后 SARS-CoV-2 特异性细胞和体液免疫的纵向动力学。
PLoS Pathog. 2021 Dec 28;17(12):e1010211. doi: 10.1371/journal.ppat.1010211. eCollection 2021 Dec.
5
Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination.分析接种 COVID-19 疫苗的类型和不良反应。
JAMA Netw Open. 2021 Dec 1;4(12):e2140364. doi: 10.1001/jamanetworkopen.2021.40364.
6
Symptomology following mRNA vaccination against SARS-CoV-2.mRNA 疫苗接种后出现的 SARS-CoV-2 症状。
Prev Med. 2021 Dec;153:106860. doi: 10.1016/j.ypmed.2021.106860. Epub 2021 Oct 20.
7
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine.接种 BNT162b2 mRNA 疫苗 6 个月后对 SARS-CoV-2 特异性记忆 B 细胞的证据。
Front Immunol. 2021 Sep 28;12:740708. doi: 10.3389/fimmu.2021.740708. eCollection 2021.
8
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.大型医疗机构中接种新冠疫苗后的心肌炎。
N Engl J Med. 2021 Dec 2;385(23):2132-2139. doi: 10.1056/NEJMoa2110737. Epub 2021 Oct 6.
9
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.辉瑞-BioNTech 新冠疫苗接种 6 个月后免疫体液反应逐渐减弱。
N Engl J Med. 2021 Dec 9;385(24):e84. doi: 10.1056/NEJMoa2114583. Epub 2021 Oct 6.
10
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.2021年3月至8月美国Moderna、辉瑞-生物科技公司和杨森（强生）疫苗在预防无免疫功能低下状况成年人新冠病毒肺炎住院方面的比较效果
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1337-1343. doi: 10.15585/mmwr.mm7038e1.